JOURNAL ARTICLE

Synthesis, <i>In Vitro</i> Anticancer Activity and <i>In Silico</i> Study of some Benzylidene Hydrazide Derivatives

Abstract

Some benzylidenehydrazides (3a-e) have been synthesized in three reaction steps from anthranilic acid in good yields, about 70% - 99%. The structures of the synthesized compounds were analyzed using spectroscopic methods. The compounds were evaluated its activity against human lung cancer, A549 cell line by MTT method and studied its molecular docking onto the protein tyrosine kinase (PDB ID: 1M17) by using Molegro® vs. 5.5. The data showed that N-(2-(2-(4-nitrobenzylidene)hydrazinecarbonyl)phenyl)benzamide (3d) which synthesized in 70% yield and has the highest activity on inhibiting the growth of A549 cell line with IC 50 10.9μg/mL, which was linier with our in silico study. Compound 3d has the smallest RS value -94.44 kcal/mol, lower than selected Ligand, Erlotinib.

Keywords:
Hydrazide Chemistry Benzamide In silico In vitro Protein Data Bank (RCSB PDB) Docking (animal) Erlotinib Cell culture Stereochemistry Nuclear chemistry Biochemistry Combinatorial chemistry Organic chemistry Biology Receptor Epidermal growth factor receptor

Metrics

3
Cited By
0.38
FWCI (Field Weighted Citation Impact)
11
Refs
0.51
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Synthesis and biological activity
Physical Sciences →  Chemistry →  Organic Chemistry
Computational Drug Discovery Methods
Physical Sciences →  Computer Science →  Computational Theory and Mathematics
Multicomponent Synthesis of Heterocycles
Physical Sciences →  Chemistry →  Organic Chemistry

Related Documents

JOURNAL ARTICLE

<i>In</i><i>-</i><i>vitro</i> Antitoxin Activity of <i>Pittosporum n</i><i>eelgherrense </i>Aqueous Bark Extract against <i>Daboia r</i><i>usselii </i>Venom

S. Priya GraceAnil KumarT. Srinivasan

Journal:   Applied ecology and environmental sciences/Applied ecology and environmental science Year: 2022 Vol: 10 (7)Pages: 453-460
© 2026 ScienceGate Book Chapters — All rights reserved.